Dash Acquisitions’s AbbVie ABBV Stock Holding History

Dash Acquisitions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$499K	Buy	2,006 +71	+4%	+$15.3K	0.1%	48
2026 Q1	$394K	Sell	1,935 -130	-6%	-$28.8K	0.08%	48
2025 Q4	$448K	Hold	2,065	–	–	0.09%	46
2025 Q3	$465K	Hold	2,065	–	–	0.09%	50
2025 Q2	$393K	Buy	2,065 +1	+0%	+$186	0.08%	40
2025 Q1	$388K	Sell	2,064 -800	-28%	-$156K	0.09%	38
2024 Q4	$501K	Buy	2,864 +23	+0.8%	+$4.23K	0.11%	36
2024 Q3	$534K	Hold	2,841	–	–	0.13%	36
2024 Q2	$498K	Sell	2,841 -38	-1%	-$6.29K	0.14%	34
2024 Q1	$473K	Sell	2,879 -971	-25%	-$167K	0.15%	33
2023 Q4	$635K	Hold	3,850	–	–	0.23%	30
2023 Q3	$571K	Hold	3,850	–	–	0.23%	31
2023 Q2	$519K	Buy	+3,850	New	+$565K	0.21%	32

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dash Acquisitions's ABBV Position: Q2 2026 in Review

Dash Acquisitions increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $15.3K and bringing the position to 2,006 shares worth $499K. The position accounts for 0.1% of the portfolio, ranked #48.

Dash Acquisitions first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. The position peaked at $635K in Q4 2023. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Dash Acquisitions held 2,006 shares of AbbVie worth $499K as of Q2 2026.
Dash Acquisitions bought 71 AbbVie shares in Q2 2026, an estimated $15.3K.
AbbVie made up 0.1% of Dash Acquisitions's portfolio in Q2 2026, its #48 holding.
Dash Acquisitions first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
Dash Acquisitions's AbbVie position peaked at $635K in Q4 2023.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Dash Acquisitions's 13F filing for Q2 2026, filed 13 Aug 2026.